Skip to main content
Top
Published in: Radiation Oncology 1/2009

Open Access 01-12-2009 | Research

Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis

Authors: Cem Onal, Erkan Topkan, Esma Efe, Melek Yavuz, Serhat Sonmez, Aydin Yavuz

Published in: Radiation Oncology | Issue 1/2009

Login to get access

Abstract

Background

To evaluate the impact of four different rectum contouring techniques and rectal toxicities in patients with treated with 3D conformal radiotherapy (3DCRT).

Methods

Clinical and dosimetric data were evaluated for 94 patients who received a total dose 3DCRT of 70 Gy, and rectal doses were compared in four different rectal contouring techniques: the prostate-containing CT sections (method 1); 1 cm above and below the planning target volume (PTV) (method 2); 110 mm starting from the anal verge (method 3); and from the anal verge to the sigmoid flexure (method 4). The percentage of rectal volume receiving RT doses (30–70 Gy) and minimum, mean rectal doses were assessed.

Results

Median age was 69 years. Percentage of rectal volume receiving high doses (≥ 70 Gy) were higher with the techniques that contoured smaller rectal volumes. In methods 2 and 3, the percentage of rectal volume receiving ≥ 70 Gy was significantly higher in patients with than without rectal bleeding (method 2: 30.8% vs. 22.5%, respectively (p = 0.03); method 3: 26.9% vs. 18.1%, respectively (p = 0.006)). Mean rectal dose was significant predictor of rectal bleeding only in method 3 (48.8 Gy in patients with bleeding vs. 44.4 Gy in patients without bleeding; p = 0.02).

Conclusion

Different techniques of rectal contouring significantly influence the calculation of radiation doses to the rectum and the prediction of rectal toxicity. Rectal volume receiving higher doses (≥ 70 Gy) and mean rectal doses may significantly predict rectal bleeding for techniques contouring larger rectal volumes, as was in method 3.
Literature
1.
go back to reference Hanks GE, Hanlon AL, Epstein B, Horwitz EM: Dose response in prostate cancer with 8–12 years' follow-up. Int J Radiat Oncol Biol Phys 2002, 54: 427-435.CrossRefPubMed Hanks GE, Hanlon AL, Epstein B, Horwitz EM: Dose response in prostate cancer with 8–12 years' follow-up. Int J Radiat Oncol Biol Phys 2002, 54: 427-435.CrossRefPubMed
2.
go back to reference Zelefsky MJ, Yamada Y, Fuks Z, Zhang Z, Hunt M, Cahlon O, Park J, Shippy A: Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 2008, 71: 1028-1033.CrossRefPubMed Zelefsky MJ, Yamada Y, Fuks Z, Zhang Z, Hunt M, Cahlon O, Park J, Shippy A: Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 2008, 71: 1028-1033.CrossRefPubMed
3.
go back to reference Nutting CM, Corbishley CM, Sanchez-Nieto B, Cosgrove VP, Webb S, Dearnaley DP: Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy. Br J Radiol 2002, 75: 151-161.CrossRefPubMed Nutting CM, Corbishley CM, Sanchez-Nieto B, Cosgrove VP, Webb S, Dearnaley DP: Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy. Br J Radiol 2002, 75: 151-161.CrossRefPubMed
4.
go back to reference O'Donnell HE, Finnegan K, Eliades H, Oliveros S, Plowman PN: Re-defining rectal volume and DVH for analysis of rectal morbidity risk after radiotherapy for early prostate cancer. Br J Radiol 2008, 81: 327-332. 10.1259/bjr/75868623CrossRefPubMed O'Donnell HE, Finnegan K, Eliades H, Oliveros S, Plowman PN: Re-defining rectal volume and DVH for analysis of rectal morbidity risk after radiotherapy for early prostate cancer. Br J Radiol 2008, 81: 327-332. 10.1259/bjr/75868623CrossRefPubMed
5.
go back to reference Nguyen LN, Pollack A, Zagars GK: Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire. Urology 1998, 51: 991-997. 10.1016/S0090-4295(98)00028-4CrossRefPubMed Nguyen LN, Pollack A, Zagars GK: Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire. Urology 1998, 51: 991-997. 10.1016/S0090-4295(98)00028-4CrossRefPubMed
6.
go back to reference Zelefsky MJ, Cowen D, Fuks Z, Shike M, Burman C, Jackson A, Venkatramen ES, Leibel SA: Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 1999, 85: 2460-2468. 10.1002/(SICI)1097-0142(19990601)85:11<2460::AID-CNCR23>3.0.CO;2-NCrossRefPubMed Zelefsky MJ, Cowen D, Fuks Z, Shike M, Burman C, Jackson A, Venkatramen ES, Leibel SA: Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 1999, 85: 2460-2468. 10.1002/(SICI)1097-0142(19990601)85:11<2460::AID-CNCR23>3.0.CO;2-NCrossRefPubMed
7.
go back to reference Schultheiss TE, Lee WR, Hunt MA, Hanlon AL, Peter RS, Hanks GE: Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997, 37: 3-11.CrossRefPubMed Schultheiss TE, Lee WR, Hunt MA, Hanlon AL, Peter RS, Hanks GE: Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997, 37: 3-11.CrossRefPubMed
8.
go back to reference Boersma LJ, Brink M, Bruce AM, Shouman T, Gras L, te Velde A, Lebesque JV: Estimation of the incidence of late bladder and rectum complications after high-dose (70–78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 1998, 41: 83-92.CrossRefPubMed Boersma LJ, Brink M, Bruce AM, Shouman T, Gras L, te Velde A, Lebesque JV: Estimation of the incidence of late bladder and rectum complications after high-dose (70–78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 1998, 41: 83-92.CrossRefPubMed
9.
go back to reference Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I: Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 2000, 48: 635-642.CrossRefPubMed Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I: Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 2000, 48: 635-642.CrossRefPubMed
10.
go back to reference Fiorino C, Cozzarini C, Vavassori V, Sanguineti G, Bianchi C, Cattaneo GM, Foppiano F, Magli A, Piazzolla A: Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. Radiother Oncol 2002, 64: 1-12. 10.1016/S0167-8140(02)00147-0CrossRefPubMed Fiorino C, Cozzarini C, Vavassori V, Sanguineti G, Bianchi C, Cattaneo GM, Foppiano F, Magli A, Piazzolla A: Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. Radiother Oncol 2002, 64: 1-12. 10.1016/S0167-8140(02)00147-0CrossRefPubMed
11.
go back to reference Fiorino C, Sanguineti G, Cozzarini C, Fellin G, Foppiano F, Menegotti L, Piazzolla A, Vavassori V, Valdagni R: Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 2003, 57: 953-962.CrossRefPubMed Fiorino C, Sanguineti G, Cozzarini C, Fellin G, Foppiano F, Menegotti L, Piazzolla A, Vavassori V, Valdagni R: Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 2003, 57: 953-962.CrossRefPubMed
12.
go back to reference Huang EH, Pollack A, Levy L, Starkschall G, Dong L, Rosen I, Kuban DA: Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002, 54: 1314-1321.CrossRefPubMed Huang EH, Pollack A, Levy L, Starkschall G, Dong L, Rosen I, Kuban DA: Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002, 54: 1314-1321.CrossRefPubMed
13.
go back to reference Beckendorf V, Guerif S, Le Prise E, Cosset JM, Lefloch O, Chauvet B, Salem N, Chapet O, Bourdin S, Bachaud JM, Maingon P, Lagrange JL, Malissard L, Simon JM, Pommier P, Hay MH, Dubray B, Luporsi E, Bey P: The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity. Int J Radiat Oncol Biol Phys 2004, 60: 1056-1065.CrossRefPubMed Beckendorf V, Guerif S, Le Prise E, Cosset JM, Lefloch O, Chauvet B, Salem N, Chapet O, Bourdin S, Bachaud JM, Maingon P, Lagrange JL, Malissard L, Simon JM, Pommier P, Hay MH, Dubray B, Luporsi E, Bey P: The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity. Int J Radiat Oncol Biol Phys 2004, 60: 1056-1065.CrossRefPubMed
14.
go back to reference Miralbell R, Taussky D, Rinaldi O, Lomax A, Canales S, Escude L, Nouet P, Ozsoy O, Rouzaud M: Influence of rectal volume changes during radiotherapy for prostate cancer: a predictive model for mild-to-moderate late rectal toxicity. Int J Radiat Oncol Biol Phys 2003, 57: 1280-1284.CrossRefPubMed Miralbell R, Taussky D, Rinaldi O, Lomax A, Canales S, Escude L, Nouet P, Ozsoy O, Rouzaud M: Influence of rectal volume changes during radiotherapy for prostate cancer: a predictive model for mild-to-moderate late rectal toxicity. Int J Radiat Oncol Biol Phys 2003, 57: 1280-1284.CrossRefPubMed
15.
go back to reference Chism DB, Horwitz EM, Hanlon AL, Pinover WH, Mitra RK, Hanks GE: Late morbidity profiles in prostate cancer patients treated to 79–84 Gy by a simple four-field coplanar beam arrangement. Int J Radiat Oncol Biol Phys 2003, 55: 71-77. 10.1016/S0360-3016(02)03822-1CrossRefPubMed Chism DB, Horwitz EM, Hanlon AL, Pinover WH, Mitra RK, Hanks GE: Late morbidity profiles in prostate cancer patients treated to 79–84 Gy by a simple four-field coplanar beam arrangement. Int J Radiat Oncol Biol Phys 2003, 55: 71-77. 10.1016/S0360-3016(02)03822-1CrossRefPubMed
16.
go back to reference Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, von Eschenbach AC, Kuban DA, Rosen I: Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002, 53: 1097-1105. 10.1016/S0360-3016(02)02829-8CrossRefPubMed Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, von Eschenbach AC, Kuban DA, Rosen I: Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002, 53: 1097-1105. 10.1016/S0360-3016(02)02829-8CrossRefPubMed
17.
go back to reference Koper PC, Heemsbergen WD, Hoogeman MS, Jansen PP, Hart GA, Wijnmaalen AJ, van Os M, Boersma LJ, Lebesque JV, Levendag P: Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 2004, 58: 1072-1082.CrossRefPubMed Koper PC, Heemsbergen WD, Hoogeman MS, Jansen PP, Hart GA, Wijnmaalen AJ, van Os M, Boersma LJ, Lebesque JV, Levendag P: Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 2004, 58: 1072-1082.CrossRefPubMed
18.
go back to reference Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, Lebesque JV, Koper PC: Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 2005, 61: 1019-1034.CrossRefPubMed Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, Lebesque JV, Koper PC: Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 2005, 61: 1019-1034.CrossRefPubMed
19.
go back to reference Nuyttens JJ, Milito S, Rust PF, Turrisi AT 3rd: Dose-volume relationship for acute side effects during high dose conformal radiotherapy for prostate cancer. Radiother Oncol 2002, 64: 209-214. 10.1016/S0167-8140(02)00185-8CrossRefPubMed Nuyttens JJ, Milito S, Rust PF, Turrisi AT 3rd: Dose-volume relationship for acute side effects during high dose conformal radiotherapy for prostate cancer. Radiother Oncol 2002, 64: 209-214. 10.1016/S0167-8140(02)00185-8CrossRefPubMed
20.
go back to reference Lawton CA, Won M, Pilepich MV, Asbell SO, Shipley WU, Hanks GE, Cox JD, Perez CA, Sause WT, Doggett SR: Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 1991, 21: 935-939.CrossRefPubMed Lawton CA, Won M, Pilepich MV, Asbell SO, Shipley WU, Hanks GE, Cox JD, Perez CA, Sause WT, Doggett SR: Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 1991, 21: 935-939.CrossRefPubMed
21.
go back to reference Michalski JM, Purdy JA, Winter K, Roach M 3rd, Vijayakumar S, Sandler HM, Markoe AM, Ritter MA, Russell KJ, Sailer S, Harms WB, Perez CA, Wilder RB, Hanks GE, Cox JD: Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 2000, 46: 391-402. 10.1016/S0360-3016(99)00443-5CrossRefPubMed Michalski JM, Purdy JA, Winter K, Roach M 3rd, Vijayakumar S, Sandler HM, Markoe AM, Ritter MA, Russell KJ, Sailer S, Harms WB, Perez CA, Wilder RB, Hanks GE, Cox JD: Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 2000, 46: 391-402. 10.1016/S0360-3016(99)00443-5CrossRefPubMed
22.
go back to reference Pollack A, Smith LG, von Eschenbach AC: External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era. Int J Radiat Oncol Biol Phys 2000, 48: 507-512.CrossRefPubMed Pollack A, Smith LG, von Eschenbach AC: External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era. Int J Radiat Oncol Biol Phys 2000, 48: 507-512.CrossRefPubMed
23.
go back to reference Fiorino C, Vavassori V, Sanguineti G, Bianchi C, Cattaneo GM, Piazzolla A, Cozzarini C: Rectum contouring variability in patients treated for prostate cancer: impact on rectum dose-volume histograms and normal tissue complication probability. Radiother Oncol 2002, 63: 249-255. 10.1016/S0167-8140(01)00469-8CrossRefPubMed Fiorino C, Vavassori V, Sanguineti G, Bianchi C, Cattaneo GM, Piazzolla A, Cozzarini C: Rectum contouring variability in patients treated for prostate cancer: impact on rectum dose-volume histograms and normal tissue complication probability. Radiother Oncol 2002, 63: 249-255. 10.1016/S0167-8140(01)00469-8CrossRefPubMed
24.
go back to reference Liu M, Berthelet E, Patterson K, Dick K, Kwan W: Various techniques of contouring the rectum and their impact on rectal dose-volume histograms. Med Dosim 2003, 28: 189-192. 10.1016/S0958-3947(03)00071-2CrossRefPubMed Liu M, Berthelet E, Patterson K, Dick K, Kwan W: Various techniques of contouring the rectum and their impact on rectal dose-volume histograms. Med Dosim 2003, 28: 189-192. 10.1016/S0958-3947(03)00071-2CrossRefPubMed
25.
go back to reference Zapatero A, Garcia-Vicente F, Modolell I, Alcantara P, Floriano A, Cruz-Conde A, Torres JJ, Perez-Torrubia A: Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect. Int J Radiat Oncol Biol Phys 2004, 59: 1343-1351.CrossRefPubMed Zapatero A, Garcia-Vicente F, Modolell I, Alcantara P, Floriano A, Cruz-Conde A, Torres JJ, Perez-Torrubia A: Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect. Int J Radiat Oncol Biol Phys 2004, 59: 1343-1351.CrossRefPubMed
26.
go back to reference Geinitz H, Zimmermann FB, Narkwong L, Kneschaurek P, Wehrmann R, Kuzmany A, Molls M: [Prostatic carcinoma: problems in the interpretation of rectal dose-volume histograms]. Strahlenther Onkol 2000, 176: 168-172. 10.1007/s000660050052CrossRefPubMed Geinitz H, Zimmermann FB, Narkwong L, Kneschaurek P, Wehrmann R, Kuzmany A, Molls M: [Prostatic carcinoma: problems in the interpretation of rectal dose-volume histograms]. Strahlenther Onkol 2000, 176: 168-172. 10.1007/s000660050052CrossRefPubMed
27.
go back to reference Boehmer D, Kuczer D, Badakhshi H, Stiefel S, Kuschke W, Wernecke KD, Budach V: Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy. Strahlenther Onkol 2006, 182: 277-282. 10.1007/s00066-006-1462-7CrossRefPubMed Boehmer D, Kuczer D, Badakhshi H, Stiefel S, Kuschke W, Wernecke KD, Budach V: Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy. Strahlenther Onkol 2006, 182: 277-282. 10.1007/s00066-006-1462-7CrossRefPubMed
Metadata
Title
Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis
Authors
Cem Onal
Erkan Topkan
Esma Efe
Melek Yavuz
Serhat Sonmez
Aydin Yavuz
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2009
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/1748-717X-4-14

Other articles of this Issue 1/2009

Radiation Oncology 1/2009 Go to the issue